申请人:A. Ebbie Soroudi, M.D., M.S., A Professional Medical Corporation
公开号:US10695290B2
公开(公告)日:2020-06-30
A non-irritation, non-blurring, photostable ophthalmic sunscreen composition contains at least one of the following: bemotrizinol; bisoctrizole; tris-biphenyl triazine; and/or octyl methoxycinnamate. A liquid vehicle base is then a remainder of the solution by weight. The composition is an artificial tear formulation or an ophthalmic suspension or ointment. The composition may include at least one inorganic and/or at least one organic active ingredient. The inorganic active ingredients may include, but not be limited to zinc oxide, titanium dioxide, iron oxide, zirconium oxide, and cerium oxide. The organic active ingredients may include, but not be limited to dioxybenzone, octinoxate, octisalate, homosalate, avobenzone, octocrylene, para-aminobenzoic acid, cinoxate, methyl anthranilate, octocrylene, padimate O, ensulizole, sulisobenzone, trolamine salicylate, and ecamsule.
一种无刺激、不模糊、光稳定性好的眼科防晒组合物至少含有以下一种成分:贝莫三嗪醇;双辛唑;三联苯三嗪;和/或甲氧基肉桂酸辛酯。按重量计,液体载体基为溶液的剩余部分。该组合物是一种人工泪液制剂或眼科混悬液或软膏。组合物可包括至少一种无机活性成分和/或至少一种有机活性成分。无机活性成分可包括但不限于氧化锌、二氧化钛、氧化铁、氧化锆和氧化铈。有机活性成分可包括但不限于二氧苯酮、辛氧酯、辛沙酯、高水杨酸酯、阿伏苯酮、辛丙烯、对氨基苯甲酸、辛氧酯、蒽酸甲酯、辛丙烯、Padimate O、安舒利唑、舒利苄、水杨酸曲拉明和ecamsule。